HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duverger, A. Articles by Boyaka, P. N. Search for Related Content PubMed PubMed Citation Articles by Duverger, A. Articles by Boyaka, P. N.

Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens¹

Alexandra Duverger^*, Raymond J. Jackson^*, Frederick W. van Ginkel^2,*, Romy Fischer^*, Angela Tafaro^*, Stephen H. Leppla, Kohtaro Fujihashi^*,, Hiroshi Kiyono^,, Jerry R. McGhee^* and Prosper N. Boyaka^3,*

^* Department of Microbiology and Department of Pediatric Dentistry, University of Alabama at Birmingham, Birmingham, AL 35294; Microbial Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and Division of Mucosal Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, University of Tokyo, Tokyo, Japan

Anthrax edema toxin (EdTx) is an AB-type toxin that binds to anthrax toxin receptors on target cells via the binding subunit, protective Ag (PA). Edema factor, the enzymatic A subunit of EdTx, is an adenylate cyclase. We found that nasal delivery of EdTx enhanced systemic immunity to nasally coadministered OVA and resulted in high OVA-specific plasma IgA and IgG (mainly IgG1 and IgG2b). The edema factor also enhanced immunity to the binding PA subunit itself and promoted high levels of plasma IgG and IgA responses as well as neutralizing PA Abs. Mice given OVA and EdTx also exhibited both PA- and OVA-specific IgA and IgG Ab responses in saliva as well as IgA Ab responses in vaginal washes. EdTx as adjuvant triggered OVA- and PA-specific CD4⁺ T cells which secreted IFN- and selected Th2-type cytokines. The EdTx up-regulated costimulatory molecule expression by APCs but was less effective than cholera toxin for inducing IL-6 responses either by APCs in vitro or in nasal washes in vivo. Finally, nasally administered EdTx did not target CNS tissues and did not induce IL-1 mRNA responses in the nasopharyngeal-associated lymphoepithelial tissue or in the olfactory bulb epithelium. Thus, EdTx derivatives could represent an alternative to the ganglioside-binding enterotoxin adjuvants and provide new tools for inducing protective immunity to PA-based anthrax vaccines.

This article has been cited by other articles:

				J.-H. Song, H. H. Nguyen, N. Cuburu, T. Horimoto, S.-Y. Ko, S.-H. Park, C. Czerkinsky, and M.-N. Kweon From the Cover: Sublingual vaccination with influenza virus protects mice against lethal viral infection PNAS, February 5, 2008; 105(5): 1644 - 1649. [Abstract] [Full Text] [PDF]

				H. F. Nawar, S. Arce, M. W. Russell, and T. D. Connell Mutants of Type II Heat-Labile Enterotoxin LT-IIa with Altered Ganglioside-Binding Activities and Diminished Toxicity Are Potent Mucosal Adjuvants Infect. Immun., February 1, 2007; 75(2): 621 - 633. [Abstract] [Full Text] [PDF]

				K. Oguma and J.-C. Lee Authors' reply Microbiology, July 1, 2006; 152(7): 1895 - 1897. [Full Text] [PDF]